Intranet
Marion Kerioui | IAME
Marion Kerioui - Former member -

Publications

Viral and immune dynamics of genital human papillomavirus infections in young women with high temporal resolution

2025

DOI

PubMed

Copy reference

PLoS biology

Tessandier N et al.Tessandier N, Elie B, Boué V, Selinger C, Rahmoun M, Bernat C, Grasset S, Groc S, Bedin AS, Beneteau T, Bonneau M, Graf C, Jacobs N, Kamiya T, Kerioui M, Lajoie J, Melki I, Prétet JL, Reyné B, Schlecht-Louf G, Sofonea MT, Supplisson O, Wymant C, Foulongne V, Guedj J, Hirtz C, Picot MC, Reynes J, Tribout V, Tuaillon É, Waterboer T, Segondy M, Bravo IG, Boulle N, Murall CL, Alizon S

New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models

2024

DOI

PubMed

Copy reference

Statistical Methods in Medical Research

Kerioui M et al.Kerioui M, Iasonos A, Gönen M, Arfé A

Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management

2024

DOI

PubMed

Copy reference

Diseases of the Colon and Rectum

Feferman Y et al.Feferman Y, Rosen RY, Gebran S, Yuval JB, Kerioui M, Gönen M, Wei IH, Widmar M, Nash GM, Weiser MR, Paty PB, Hajj C, Roth O'Brien DA, Romesser PB, Crane CH, Smith JJ, Garcia Aguilar J, Pappou EP

Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancer

2023

DOI

PubMed

Copy reference

Biometrics

Kerioui M et al.Kerioui M, Beaulieu M, Desmée S, Bertrand J, Mercier F, Jin JY, Bruno R, Guedj J

Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?

2023

DOI

PubMed

Copy reference

JCO precision oncology

Kerioui M et al.Kerioui M, Bertrand J, Desmée S, Le Tourneau C, Mercier F, Bruno R, Guedj J

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates

2023

DOI

PubMed

Copy reference

PLoS computational biology

Marc A et al.Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J

Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models

2022

DOI

PubMed

Copy reference

British Journal of Clinical Pharmacology

Kerioui M et al.Kerioui M, Bertrand J, Bruno R, Mercier F, Guedj J, Desmée S

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy

2022

DOI

PubMed

Copy reference

ESMO open

Kerioui M et al.Kerioui M, Desmée S, Mercier F, Lin A, Wu B, Jin JY, Shen X, Le Tourneau C, Bruno R, Guedj J

Quantifying the relationship between SARS-CoV-2 viral load and infectiousness

2021

DOI

PubMed

Copy reference

eLife

Marc A et al.Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy

2020

DOI

PubMed

Copy reference

Statistics in Medicine

Kerioui M et al.Kerioui M, Mercier F, Bertrand J, Tardivon C, Bruno R, Guedj J, Desmée S

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment

2020

DOI

PubMed

Copy reference

Journal of Pharmacokinetics and Pharmacodynamics

Mercier F et al.Mercier F, Kerioui M, Desmée S, Guedj J, Krieter O, Bruno R

Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up

2019

DOI

PubMed

Copy reference

Clinical Pharmacology and Therapeutics

Tardivon C et al.Tardivon C, Desmée S, Kerioui M, Bruno R, Wu B, Mentré F, Mercier F, Guedj J